MILTENYI CLINIMACS CD34+ SELECTION SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-06-23 for MILTENYI CLINIMACS CD34+ SELECTION SYSTEM manufactured by Miltenyi.

Event Text Entries

[78578120] The cd34 selection took place efficiently, however products were cryopreserved in vials. The cryopreserved vials for pbsc and lymphocytes for pt to be transplanted on (b)(6) 2017 appear to have been partially unscrewed (2 rungs) likely due to vial overfilling. No product spillage occurred into the sterile bag covers in which the products were placed. Consequently, no cell loss appears to have occurred and the vials appear full, however, this medwatch is being reported because a potential breach of sterility and potential loss of cells.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5070646
MDR Report Key6669586
Date Received2017-06-23
Date of Report2017-06-23
Date of Event2017-06-20
Date Added to Maude2017-06-27
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameMILTENYI CLINIMACS CD34+ SELECTION SYSTEM
Generic NameMAGNETIC CELL SELECTION SYSTEM FOR CD34+ CELLS
Product CodeOVG
Date Received2017-06-23
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerMILTENYI
Manufacturer AddressUS


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-06-23

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.